Discover and read the best of Twitter Threads about #overpatenting
Most recents (3)
Despite what the CEO of Celgene/BMS has said in this hearing, it's important to note that even though Natco will enter with a generic version of Revlimid in 2022 it will be a very restricted amount.
The settlement between Natco/Celgene prevents Natco from fully coming to market until 2026. Other generics are still in litigation with Celgene BMS because of all the "important patent innovations" that Celegene piled up.
One of those "important innovations" is a patent on the crystalline form of lenalidomide which expires in 2027. A graduate student in organic chemistry would know how to get a crystalline form of a compound because it's just so obvious.
"After 10 years under the BPCIA, patents, in many cases scores of patents per product, are providing originators with years of additional exclusivity."bit.ly/2pZxl4N
"Every FDA-approved biosimilar has faced a patent challenge, and on average at least 80 patents have been either asserted or disclosed as potentially covering the biosimilar."
"Biologics originators successfully argued that they required longer [marketing] exclusivity without competition from follow-on products because patents covering the originators’ products would not pose the same barriers to entry that patents provide for small molecule drugs."
"America's patent system should reward innovation, not lawyering." Absolutely. But the elephant in the room that urgently needs tackling to solve this problem is "what is innovation" when it comes to deserving a patent under the patent system? bit.ly/2O41qvL
I keep hearing in discussions on how to tackle the #overpatenting/ patent abuse problem that "patents should only be granted for "real and meaningful innovation". What does that even mean?
I feel sometimes that we publicly dare not get into the weeds in case we sound "anti-innovation" or "progress" and #pharma won't invest in new medicines if we challenge the meaning too much. It's as if "innovation" is some religion and we walk on egg shells when criticising it.
